Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Cephalosporin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027

Market Overview:

The global cephalosporin market reached a value of US$ 18.04 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 21.69 Billion by 2027, exhibiting at a CAGR of 2.97% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.

Cephalosporins are beta-lactam antibiotics that function in the way similar to penicillin. These broad-spectrum drugs help in treating numerous bacterial infections such as pneumonia, kidney infections, bone infections, meningitis and various sexually transmitted diseases (STDs). There are currently five generations of cephalosporin drugs available in the market with a slight difference in their antibacterial spectrum. These medicines are also differentiated on the basis their administration, excretion, absorption and the duration of the effect of cephalosporin on the body. There are two ways to administer cephalosporin drugs, namely, oral and intravenous (IV). A course of oral cephalosporins is generally used for curing minor infections that are easy to treat such as strep throat. Whereas, IVs are utilized for more severe infections, like meningitis, as these medicines reach tissues quickly than those administered orally.

At present, the rapidly increasing water and air pollution are the primary reasons for the prevalence of infectious diseases across the globe. This has provided a boost to the demand for cephalosporin drugs worldwide. Other than this, various organizations around the world are taking initiatives to improve the development and delivery of antibiotic treatments. One such program is the Global Antibiotic Research and Development Partnership (GARDP), which is a not-for-profit R&D organization formed by the Drugs for Neglected Disease initiative (DNDi) and World Health Organization (WHO). It focusses on the promotion of public-private partnerships for increasing R&D of new antimicrobial diagnostics and agents. The formation of these partnerships is expected to play a significant role in the growth of the cephalosporin market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global cephalosporin market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on generation, route of administration and application.

Breakup by Generation:

  • First Generation 
  • Second Generation
  • Third Generation
  • Fourth Generation
  • Fifth Generation
     

Breakup by Route of Administration:

  • Injection
  • Oral
     

Breakup by Application:

  • Respiratory Tract
  • Skin Infection
  • Ear Infection
  • Urinary Tract Infection
  • Sexually Transmitted Infection
  • Others
     

Breakup by Region:

  • Asia Pacific
  • Europe
  • North America
  • Middle East and Africa
  • Latin America
     

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being Allergan Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Lupin Limited, Merck & Co. Inc., Novartis International AG (Sandoz), Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Abbott, Sun Pharmaceutical Industries Limited, etc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2021
Historical Period 2016-2021
Forecast Period 2022-2027
Units US$ Billion
Segment Coverage Generation, Route of Administration, Application, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Companies Covered Allergan Plc., Bristol-Myers Squibb Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Lupin Limited, Merck & Co. Inc., Novartis International AG (Sandoz), Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Abbott and Sun Pharmaceutical Industries Limited
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Cephalosporin Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Breakup by Generation
    5.5    Market Breakup by Route of Administration
    5.6    Market Breakup by Application
    5.7    Market Breakup by Region
    5.8    Market Forecast
6   Market Breakup by Generation
    6.1    First Generation
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Second Generation
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Third Generation
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Fourth Generation
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Fifth Generation
        6.5.1    Market Trends
        6.5.2    Market Forecast
7   Market Breakup by Route of Administration
    7.1    Injection
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Oral
        7.2.1    Market Trends
        7.2.2    Market Forecast
8   Market Breakup by Application
    8.1    Respiratory Tract
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Skin Infection
        8.2.1    Market Trends
        8.2.2    Market Forecast
    8.3    Ear Infection
        8.3.1    Market Trends
        8.3.2    Market Forecast
    8.4    Urinary Tract Infection
        8.4.1    Market Trends
        8.4.2    Market Forecast
    8.5    Sexually Transmitted Infection
        8.5.1    Market Trends
        8.5.2    Market Forecast
    8.6    Others
        8.6.1    Market Trends
        8.6.2    Market Forecast
9   Market Breakup by Region
    9.1    Asia Pacific
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Europe
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    North America
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Middle East and Africa
        9.4.1    Market Trends
        9.4.2    Market Forecast
    9.5    Latin America
        9.5.1    Market Trends
        9.5.2    Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
    13.1    Price Indicators
    13.2    Price Structure
    13.3    Margin Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Allergan Plc.
        14.3.2    Bristol-Myers Squibb Company
        14.3.3    F. Hoffmann-La Roche Ltd.
        14.3.4    GlaxoSmithKline plc
        14.3.5    Lupin Limited
        14.3.6    Merck & Co. Inc.
        14.3.7    Novartis International AG (Sandoz)
        14.3.8    Pfizer Inc.
        14.3.9    Sanofi
        14.3.10    Teva Pharmaceutical Industries Ltd.
        14.3.11     Abbott
        14.3.12    Sun Pharmaceutical Industries Limited
        
List of Figures

Figure 1: Global: Cephalosporin Market: Major Drivers and Challenges
Figure 2: Global: Cephalosporin Market: Sales Value (in Billion US$), 2016 - 2021
Figure 3: Global: Cephalosporin Market: Breakup by Generation (in %), 2021
Figure 4: Global: Cephalosporin Market: Breakup by Route of Administration (in %), 2021
Figure 5: Global: Cephalosporin Market: Breakup by Application (in %), 2021
Figure 6: Global: Cephalosporin Market: Breakup by Region (in %), 2021
Figure 7: Global: Cephalosporin Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 8: Global: Cephalosporin (First Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Cephalosporin (First Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Cephalosporin (Second Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Cephalosporin (Second Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Cephalosporin (Third Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Cephalosporin (Third Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Cephalosporin (Fourth Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Cephalosporin (Fourth Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Cephalosporin (Fifth Generation) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Cephalosporin (Fifth Generation) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Cephalosporin (Injection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Cephalosporin (Injection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Cephalosporin (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Cephalosporin (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Cephalosporin (Respiratory Tract) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Cephalosporin (Respiratory Tract) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Cephalosporin (Skin Infection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Cephalosporin (Skin Infection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Cephalosporin (Ear Infection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Cephalosporin (Ear Infection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Cephalosporin (Urinary Tract Infection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Cephalosporin (Urinary Tract Infection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Cephalosporin (Sexually Transmitted Infection) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Cephalosporin (Sexually Transmitted Infection) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Cephalosporin (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Cephalosporin (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Asia Pacific: Cephalosporin Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Asia Pacific: Cephalosporin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Europe: Cephalosporin Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Europe: Cephalosporin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: North America: Cephalosporin Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: North America: Cephalosporin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Middle East and Africa: Cephalosporin Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Middle East and Africa: Cephalosporin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Latin America: Cephalosporin Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Latin America: Cephalosporin Market Forecast: Sales Value (in Million US$), 2022-2027

List of Tables

Table 1: Global: Cephalosporin Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Cephalosporin Market Forecast: Breakup by Generation (in Million US$), 2022-2027
Table 3: Global: Cephalosporin Market Forecast: Breakup by Route of Administration (in Million US$), 2022-2027
Table 4: Global: Cephalosporin Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 5: Global: Cephalosporin Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Cephalosporin Market Structure
Table 7: Global: Cephalosporin Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Key Questions Answered in This Report

The global cephalosporin market was valued at US$ 18.04 Billion in 2021.

We expect the global cephalosporin market to exhibit a CAGR of 2.97% during 2022-2027.

The high prevalence of numerous bacterial infections, such as pneumonia, kidney infections, bone
infections, meningitis, etc., is primarily driving the global cephalosporin market.

The sudden outbreak of the COVID-19 pandemic has led to extensive R&D activities for the introduction
of combination drugs, including cephalosporin, as an immediate option for effective treatment of the
coronavirus infected patients.

Based on the generation, the global cephalosporin market has been segmented into first generation,
second generation, third generation, fourth generation, and fifth generation. Among these, third
generation cephalosporin holds the majority of the total market share.

Based on the route of administration, the global cephalosporin market can be divided into injection and
oral. Currently, injection represents the largest market share.

On a regional level, the market has been classified into North America, Asia Pacific, Europe, Latin
America, and Middle East and Africa, where Asia Pacific currently dominates the global market.

Some of the major players in the global cephalosporin market include Allergan Plc., Bristol-Myers Squibb
Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline plc, Lupin Limited, Merck & Co. Inc., Novartis
International AG (Sandoz), Pfizer Inc., Sanofi, Teva Pharmaceutical Industries Ltd., Abbott, Sun
Pharmaceutical Industries Limited, etc.

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2499

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links